What is the current Price Target for the Crinetics Pharmaceuticals Inc stock?

The average Crinetics Pharmaceuticals Inc target price is $74.33. This is 150.62% higher than the current stock price. The highest price target is 237.15%, the lowest is 78.69%. 15 Analysts have issued a price target Crinetics Pharmaceuticals Inc 2026 .

How high will the Crinetics Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Crinetics Pharmaceuticals Inc stock will rise. The performance of stocks, including the Crinetics Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Crinetics Pharmaceuticals Inc stock today?

The performance of Crinetics Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Crinetics Pharmaceuticals Inc stock fall?

The decline in Crinetics Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Crinetics Pharmaceuticals Inc Forecast, price target & analysts

$29.66

0.40% yesterday

Nasdaq, Apr 15, 10:00 pm CET

ISIN

US22663K1079

Symbol

CRNX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Crinetics Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Crinetics Pharmaceuticals Inc Classifications & Recommendation:

Buy

94%

Hold

Crinetics Pharmaceuticals Inc Price Target

Target Price	$74.33
Price	$29.66
Potential	150.62% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Crinetics Pharmaceuticals Inc 2026 . The average Crinetics Pharmaceuticals Inc target price is $74.33. This is 150.62% register free of charge higher than the current stock price. The highest price target is $100.00 237.15% register free of charge , the lowest is $53.00 78.69% register free of charge .
	A rating was issued by 17 analysts: 16 Analysts recommend Crinetics Pharmaceuticals Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Crinetics Pharmaceuticals Inc stock has an average upside potential 2026 of 150.62% register free of charge . Most analysts recommend the Crinetics Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.69	-4.47
	0.00%	21.14%
P/E		negative
EV/Sales		254.09

4 Analysts have issued a Crinetics Pharmaceuticals Inc forecast for earnings per share. The average Crinetics Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.69	0.00%
2025	$-4.47 21.14% Unlock
2026	$-5.19 16.11% Unlock
2027	$-4.32 16.76% Unlock
2028	$-1.08 75.00% Unlock
2029	$3.18 394.44% Unlock

Current	-8.01	33.53%
2025	-6.64 17.10% Unlock
2026	-5.71 14.01% Unlock
2027	-6.86 20.14% Unlock
2028	-27.59 302.19% Unlock
2029	9.34 133.85% Unlock

Crinetics Pharmaceuticals Inc...

Current Crinetics Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Stifel	Locked ➜ Locked	Locked	Mar 25 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Feb 28 2025
Wolfe Research	Locked ➜ Locked	Locked	Feb 04 2025
Jefferies	Locked ➜ Locked	Locked	Jan 22 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 13 2025
JMP Securities	Locked ➜ Locked	Locked	Dec 16 2024
Citigroup	Locked ➜ Locked	Locked	Nov 14 2024

Analyst Rating	Date
Locked Stifel: Locked ➜ Locked	Mar 25 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Feb 28 2025
Locked Wolfe Research: Locked ➜ Locked	Feb 04 2025
Locked Jefferies: Locked ➜ Locked	Jan 22 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 13 2025
Locked JMP Securities: Locked ➜ Locked	Dec 16 2024
Locked Citigroup: Locked ➜ Locked	Nov 14 2024

Discover more stocks with a high price target

Novo Nordisk 78.97%

MongoDB 76.41%

TUI 64.34%

Coinbase Global, Inc. 63.76%

NVIDIA 52.36%

Infineon 52.24%

Walt Disney 46.40%

Alibaba Group Holding Ltd 45.26%

NIO ADR 44.89%

BioNTech SE - ADR 44.79%

Amazon.com 42.38%

Meta Platforms (Facebook) 40.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now